Lv3
372 积分 2024-07-29 加入
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
5小时前
已完结
Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases
5小时前
待确认
Analysis of efficacy and safety for the combination of tislelizumab and regorafenib in advanced hepatocellular carcinoma: A prospective clinical study
8小时前
已完结
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study
1天前
已完结
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
4个月前
已完结
Kupffer cell–derived Fas Ligand plays a role in liver injury and hepatocyte death
4个月前
已完结
Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids
4个月前
已完结
Single-cell and spatial transcriptomics characterisation of the immunological landscape in the healthy and PSC human liver
4个月前
已完结
Material-driven immunomodulation and ECM remodeling reverse pulmonary fibrosis by local delivery of stem cell-laden microcapsules
4个月前
已完结
Hepatic inflammatory responses in liver fibrosis
5个月前
已完结
皖公网安备34019202002308
